Skip to main content
. 2016 Sep 1;25(9):875–881. doi: 10.1089/jwh.2015.5441

Table 2.

Laboratory Measurements and Risk Factors for the Metabolic Syndrome for Women With and Without Clinical Features of Polycystic Ovary Syndrome

  PCOS (n = 25) No PCOS (n = 270) p
Cardiac risk factors, %
 Hypertension 48.0 63.3 0.29
 Diabetes mellitus 24.0 32.2 0.66
 Dyslipidemia 64.0 54.1 0.52
Total cholesterol, mg/dL 195.3 ± 36.6 197.8 ± 48.5 0.80
LDL cholesterol, mg/dL 110.1 ± 29.4 116.2 ± 42.0 0.57
HDL cholesterol, mg/dL 47.9 ± 10.3 52.5 ± 11.2 0.05
 <50 mg/dL, % 64.0 42.4 0.06
Triglycerides, mg/dL 198.7 ± 136.5 148.7 ± 88.5 0.08
 >150 mg/dL, % 52.0 42.4 0.40
Body mass index, kg/m2 28.7 ± 5.9 30.0 ± 6.7 0.37
 ≥30 kg/m2, % 36.0 40.6 0.83
Waist/hip ratio 0.89 ± 0.12 0.87 ± 0.12 0.58
 Range 0.73–1.28 0.68–1.62  
Waist circumference, inches 38.5 ± 7.6 37.9 ± 7.2 0.70
 >35 inches, % 68.0 60.2 0.52
Blood pressure, mmHg
 Systolic 141.4 ± 19.9 140.4 ± 21.6 0.84
 Diastolic 75.4 ± 12.5 76.7 ± 10.9 0.62
Age at hypertension diagnosis, years, mean ± SD 47.5 ± 11.6 50.5 ± 15.0 0.51
Fasting glucose, mg/dL 109.78 ± 46.5 121.4 ± 60.5 0.45
 >110 mg/dL, % 12.5 34.6 0.10
Age at diabetes diagnosis, years 58.4 ± 9.6 51.5 ± 12.8 0.24
Insulin resistance, HOMA 3.07 ± 5.02 5.35 ± 8.24 0.12
Fasting glucose >110 and triglycerides >150 mg/dL, % 20 18 0.81
Triglyceride/HDL ratio 4.7 ± 3.9 3.0 ± 2.0 0.05
 >3.0, % 52.0 43.0 0.41
No. of metabolic syndrome risk factors, mean ± SD 2.1 ± 1.2 1.8 ± 1.1 0.22
 0, % 12.0 10.7 0.16
 1, % 20.0 31.9  
 2, % 20.0 31.1  
 ≥3, % 48.0 26.3  

HOMA, homeostasis model assessment; LDL, low-density lipoprotein; HDL, high-density lipoprotein.